Seer Correlations
SEER Stock | USD 2.43 0.05 2.10% |
The current 90-days correlation between Seer Inc and C4 Therapeutics is 0.08 (i.e., Significant diversification). The correlation of Seer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Seer Correlation With Market
Modest diversification
The correlation between Seer Inc and DJI is 0.23 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and DJI in the same portfolio, assuming nothing else is changed.
Seer |
Moving together with Seer Stock
0.74 | EWTX | Edgewise Therapeutics | PairCorr |
0.83 | EXEL | Exelixis | PairCorr |
0.92 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.71 | WAT | Waters | PairCorr |
0.83 | GILD | Gilead Sciences | PairCorr |
Moving against Seer Stock
0.86 | VALN | Valneva SE ADR | PairCorr |
0.79 | ERNA | Eterna Therapeutics | PairCorr |
0.76 | ME | 23Andme Holding | PairCorr |
0.71 | HLN | Haleon plc | PairCorr |
0.61 | VCNX | Vaccinex | PairCorr |
0.48 | EXAS | EXACT Sciences Sell-off Trend | PairCorr |
0.4 | A | Agilent Technologies Earnings Call This Week | PairCorr |
0.4 | EQ | Equillium | PairCorr |
0.36 | DOMH | Dominari Holdings | PairCorr |
0.89 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.88 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.86 | GMAB | Genmab AS | PairCorr |
0.85 | LLY | Eli Lilly Sell-off Trend | PairCorr |
0.85 | INZY | Inozyme Pharma | PairCorr |
0.81 | LEGN | Legend Biotech Corp | PairCorr |
0.79 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.78 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
0.68 | IPSC | Century Therapeutics | PairCorr |
0.59 | YCBD | cbdMD Inc | PairCorr |
0.5 | CINGW | Cingulate Warrants | PairCorr |
0.36 | KRYS | Krystal Biotech | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Seer Stock performing well and Seer Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Seer's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ORIC | 2.87 | (0.10) | 0.00 | 0.07 | 4.26 | 6.04 | 23.18 | |||
ANEB | 5.20 | (0.27) | 0.00 | (0.03) | 0.00 | 8.85 | 76.00 | |||
CGEM | 2.87 | (0.73) | 0.00 | (0.23) | 0.00 | 5.88 | 17.85 | |||
CCCC | 3.70 | (0.61) | 0.00 | (0.28) | 0.00 | 9.57 | 23.66 | |||
MOLN | 4.66 | (0.26) | 0.00 | (0.11) | 0.00 | 9.61 | 52.92 | |||
MLYS | 2.68 | (0.08) | 0.03 | 0.09 | 3.37 | 6.27 | 20.98 | |||
ANTX | 1.90 | 0.25 | 0.08 | 0.47 | 1.86 | 3.64 | 28.03 | |||
PHVS | 2.95 | 0.22 | 0.08 | 0.29 | 2.98 | 7.76 | 21.41 | |||
PEPG | 3.05 | (1.29) | 0.00 | (0.68) | 0.00 | 4.75 | 26.81 | |||
FHTX | 4.06 | (0.21) | 0.02 | 0.06 | 4.43 | 8.50 | 34.64 |
Seer Corporate Management
Marissa Dixon | Chief Officer | Profile | |
Asim Siddiqui | Senior Development | Profile | |
Martin Goldberg | Senior Development | Profile | |
Kenny Ross | Chief Officer | Profile | |
JD Esq | Chief Secretary | Profile | |
Joe Laws | Chief CoFounder | Profile |